Found this:
MONTHLY PROGRESS REPORT - April 2018
Name of CSE Issuer THC BioMed Intl Ltd.
Trading Symbol: THC
Number of Outstanding
Listed Securities
116,413,690 common shares and 17,306,253 reserved
for Issuance
Date: May 3, 2018
Report on Business
1. Provide a general overview and discussion of the development of the Issuer’s business
and operations over the previous month. Where the Issuer was inactive disclose this
fact.
During the reporting month, the Issuer continued to explore new business
opportunities with several prospects in its target market.
On April 4, 2018, the Issuer announced that it entered into a Letter of Intent with
an Australian licensed importer and wholesaler of medical cannabis for the
acquisition of 51% of that company. The Issuer has incorporated a subsidiary in
Lesotho, Africa, for the purpose of applying to become a licensed producer in
Africa.
On April 4, 2018, the Issuer announced that is applied to Health Canada to add six
more production areas and continues to finalize the details for the purchase of the
Greenhouse and farm in Ontario.
On April 6, 2018, the Issuer announced that it had purchased an 8,000 square foot
building in downtown Kelowna which is zoned for industrial use. The city of
Kelowna permits cannabis production on industrial-zoned land (the “Kelowna
Building”).
On April 24, 2018, the Issuer announced a 5-year license agreement by its wholly-
owned subsidiary, THC2GO Dispensaries Ltd., with Bhang & Shatter, an Alberta
company for the operation of up to two retail stores in Alberta, Canada (the
“License Agreement”).
